CEL-SCI CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
CEL-SCI CORPORATION (CVM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.00 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-14
- CEL-SCI CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 1.00K shares, a 1.67% decline year-over-year.
- CEL-SCI CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 1.50K shares, a 4311.76% increase year-over-year.
- CEL-SCI CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 1.00K shares, a 94.03% decline year-over-year.
- CEL-SCI CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 1.02K shares, a 98.45% decline year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 1.00K shares 10-Q · filed 2026-08-14 | 2.50K shares derived: sum of 2 quarters · filed 2026-08-14 | 3.50K shares 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | 1.50K shares 10-Q · filed 2026-05-15 | 2.50K shares 10-Q · filed 2026-05-15 | ||||
| 2025-12-31 | 1.00K shares 10-Q · filed 2026-02-17 | |||||
| 2025-06-30 | 1.02K shares 10-Q · filed 2026-08-14 | 1.05K shares derived: sum of 2 quarters · filed 2026-08-14 | 1.14K shares 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | 34.00 shares 10-Q · filed 2026-05-15 | 1.00K shares 10-Q · filed 2025-05-14 | 16.78K shares 10-Q · filed 2026-05-15 | 503.50K shares 10-Q · filed 2025-05-14 | ||
| 2024-12-31 | 16.75K shares 10-Q · filed 2026-02-17 | 502.50K shares 10-Q · filed 2025-02-14 | ||||
| 2024-06-30 | 65.48K shares 10-Q · filed 2025-08-14 | 1.96M shares 10-Q · filed 2024-08-14 | 68.48K shares derived: sum of 2 quarters · filed 2025-08-14 | 65.58K shares 10-Q · filed 2025-08-14 | 1.97M shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 3.00K shares 10-Q · filed 2025-05-14 | 3.00K shares 10-Q · filed 2025-05-14 | ||||
| 2023-12-31 | 0.00 shares 10-Q · filed 2025-02-14 | |||||
| 2023-06-30 | 2.00K shares 10-Q · filed 2024-08-14 | 4.00K shares derived: sum of 2 quarters · filed 2024-08-14 | 6.50K shares 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | 2.00K shares 10-Q · filed 2024-05-15 | 4.50K shares 10-Q · filed 2024-05-15 | ||||
| 2022-12-31 | 2.50K shares 10-Q · filed 2024-02-14 | |||||
| 2022-06-30 | 1.72M shares 10-Q · filed 2023-08-10 | 1.72M shares derived: sum of 2 quarters · filed 2023-08-10 | 1.98M shares 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | 1.50K shares 10-Q · filed 2023-05-12 | 252.50K shares 10-Q · filed 2023-05-12 | ||||
| 2021-12-31 | 251.00K shares 10-Q · filed 2023-02-14 | |||||
| 2021-06-30 | 2.60M shares 10-Q · filed 2022-08-12 | 2.60M shares derived: sum of 2 quarters · filed 2022-08-12 | 2.60M shares 10-Q · filed 2022-08-12 | |||
| 2021-03-31 | 500.00 shares 10-Q · filed 2022-05-13 | 8.00K shares 10-Q · filed 2022-05-13 | ||||
| 2020-12-31 | 7.50K shares 10-Q · filed 2022-02-11 | |||||
| 2020-06-30 | 2.56M shares 10-Q · filed 2021-08-13 | 2.56M shares derived: sum of 2 quarters · filed 2021-08-13 | 2.56M shares 10-Q · filed 2021-08-13 | 2.56M shares 10-Q/A · filed 2020-08-11 | ||
| 2020-03-31 | 1.50K shares 10-Q · filed 2021-05-17 | 2.50K shares 10-Q · filed 2021-05-17 | ||||
| 2019-12-31 | 1.00K shares 10-Q · filed 2021-02-12 | |||||
| 2019-06-30 | 3.27M shares 10-Q/A · filed 2020-12-31 | 3.27M shares derived: sum of 2 quarters · filed 2020-12-31 | 3.27M shares 10-Q/A · filed 2020-12-31 | |||
| 2019-03-31 | 0.00 shares 10-Q/A · filed 2020-12-30 | 500.00 shares 10-Q/A · filed 2020-12-30 | ||||
| 2018-12-31 | 500.00 shares 10-Q/A · filed 2020-12-30 | |||||
| 2018-06-30 | 1.85M shares 10-Q · filed 2019-08-14 | 1.85M shares derived: sum of 2 quarters · filed 2019-08-14 | 1.86M shares 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | 0.00 shares 10-Q · filed 2019-05-14 | 10.30K shares 10-Q · filed 2019-05-14 | ||||
| 2017-12-31 | 10.30K shares 10-Q · filed 2019-02-14 | |||||
| 2017-06-30 | 39.23K shares 10-Q · filed 2018-08-14 | 39.23K shares derived: sum of 2 quarters · filed 2018-08-14 | 39.23K shares 10-Q · filed 2018-08-14 | |||
| 2017-03-31 | 0.00 shares 10-Q · filed 2018-05-15 | 0.00 shares 10-Q · filed 2018-05-15 | ||||
| 2016-12-31 | 0.00 shares 10-Q · filed 2018-02-12 | |||||
| 2016-06-30 | 0.00 shares 10-Q/A · filed 2017-12-11 | 2.40K shares derived: sum of 2 quarters · filed 2017-12-11 | 8.40K shares 10-Q/A · filed 2017-12-11 | 210.00K shares 10-Q · filed 2016-08-09 | ||
| 2016-03-31 | 2.40K shares 10-Q/A · filed 2017-12-11 | 60.00K shares 10-Q · filed 2016-05-10 | 8.40K shares 10-Q/A · filed 2017-12-11 | 210.00K shares 10-Q · filed 2016-05-10 | ||
| 2015-12-31 | 0.00 shares 10-Q/A · filed 2017-12-11 | |||||
| 2015-06-30 | 801.70K shares 10-Q · filed 2016-08-09 | 802.70K shares derived: sum of 2 quarters · filed 2016-08-09 | 803.70K shares 10-Q · filed 2016-08-09 | |||
| 2015-03-31 | 1.00K shares 10-Q · filed 2016-05-10 | 2.00K shares 10-Q · filed 2016-05-10 | ||||
| 2014-12-31 | 1.00K shares 10-Q · filed 2016-02-09 | |||||
| 2014-06-30 | 0.00 shares 10-Q · filed 2015-08-07 | 743.04K shares derived: sum of 2 quarters · filed 2015-08-07 | 743.04K shares 10-Q · filed 2015-08-07 | |||
| 2014-03-31 | 743.04K shares 10-Q · filed 2015-05-08 | 743.04K shares 10-Q · filed 2015-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |